These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 10897214

  • 1. [In vitro growth and clinical response of leukemia cells to macrophage colony-stimulating factor (M-CSF) and granulocyte colony-stimulating factor (G-CSF) in acute leukemia].
    Takeyama H, Kajiguchi T, Miyata Y, Saito M.
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):873-8. PubMed ID: 10897214
    [Abstract] [Full Text] [Related]

  • 2. A novel human myeloid leukemia cell line, NKM-1, coexpressing granulocyte colony-stimulating factor receptors and macrophage colony-stimulating factor receptors.
    Kataoka T, Morishita Y, Ogura M, Morishima Y, Towatari M, Kato Y, Inoue H, Saito H.
    Cancer Res; 1990 Dec 01; 50(23):7703-9. PubMed ID: 1701353
    [Abstract] [Full Text] [Related]

  • 3. Induction of junB expression, but not c-jun, by granulocyte colony-stimulating factor or macrophage colony-stimulating factor in the proliferative response of human myeloid leukemia cells.
    Adachi K, Saito H.
    J Clin Invest; 1992 May 01; 89(5):1657-61. PubMed ID: 1373742
    [Abstract] [Full Text] [Related]

  • 4. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O, Foss B, Petersen H.
    Eur Cytokine Netw; 2001 May 01; 12(2):231-8. PubMed ID: 11399510
    [Abstract] [Full Text] [Related]

  • 5. [Successful treatment of acute non-lymphoblastic leukemia from myelodysplastic syndrome by combination of human macrophage colony-stimulating factor (M-CSF) and low dose cytosine arabinoside: M-CSF-induced proliferation and tyrosine phosphorylation in leukemic blasts].
    Hagiwara S, Yuo A, Nagai M, Takezako N, Soda Y, Miwa A, Togawa A, Takaku F.
    Rinsho Ketsueki; 1996 Nov 01; 37(11):1259-64. PubMed ID: 8960658
    [Abstract] [Full Text] [Related]

  • 6. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK, Heil G, Zander C, Wiebe S, Ottmann OG, Bergmann L, Hoeffken K, Fischer JT, Knuth A, Kolbe K, Schmoll HJ, Langer W, Westerhausen M, Koelbel CB, Hoelzer D, Ganser A.
    Ann Hematol; 2004 Aug 01; 83(8):498-503. PubMed ID: 15156346
    [Abstract] [Full Text] [Related]

  • 7. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR.
    J Natl Cancer Inst; 2007 Feb 07; 99(3):196-205. PubMed ID: 17284714
    [Abstract] [Full Text] [Related]

  • 8. Proliferation and maturation effects of in-vivo granulocyte-macrophage colony stimulating factor in acute non-lymphocytic leukaemia.
    Damiani D, Michieli M, Revignas MG, Russo D, Fanin R, Michelutti A, Mallardi F, Baccarani M.
    Haematologica; 1992 Feb 07; 77(1):25-9. PubMed ID: 1398278
    [Abstract] [Full Text] [Related]

  • 9. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
    Gandhi V, Estey E, Du M, Nowak B, Keating MJ, Plunkett W.
    Clin Cancer Res; 1995 Feb 07; 1(2):169-78. PubMed ID: 9815970
    [Abstract] [Full Text] [Related]

  • 10. Response of the blast stem cells of acute myeloblastic leukemia to G-CSF, GM-CSF, or the ligand for C-KIT, alone or in combination.
    McCulloch EA, Minkin S, Curtis JE, Minden MD.
    Hematopathol Mol Hematol; 1996 Feb 07; 10(3):111-22. PubMed ID: 8878730
    [Abstract] [Full Text] [Related]

  • 11. In vitro expression of colony-stimulating factor genes by human acute myeloblastic leukemia cells.
    Young DC, Demetri GD, Ernst TJ, Cannistra SA, Griffin JD.
    Exp Hematol; 1988 Jun 07; 16(5):378-82. PubMed ID: 2453374
    [Abstract] [Full Text] [Related]

  • 12. Correlation between the proliferative response to granulocyte colony-stimulating factor and the positivity of transferrin receptor in acute myeloblastic leukemia cells.
    Motoji T, Mineshima M, Watanabe M, Takanashi M, Masuda M, Oshimi K, Mizoguchi H.
    J Cell Physiol; 1991 Sep 07; 148(3):421-5. PubMed ID: 1717498
    [Abstract] [Full Text] [Related]

  • 13. [Trial of combined cytosine arabinoside with granulocyte colony-stimulating factor therapy or refractory acute myeloid leukemia].
    Mori H, Kuriyama K, Tawara M, Danno Y, Fujimoto K, Tushima H, Saito M, Yamamura M, Hata T, Arimura M.
    Rinsho Ketsueki; 1995 Jul 07; 36(7):648-56. PubMed ID: 7563592
    [Abstract] [Full Text] [Related]

  • 14. Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells.
    Asano Y, Shibuya T, Okamura S, Yamaga S, Otsuka T, Niho Y.
    Cancer Res; 1987 Nov 01; 47(21):5647-8. PubMed ID: 3499216
    [Abstract] [Full Text] [Related]

  • 15. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 01; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 16. Effect of the chimeric soluble granulocyte colony-stimulating factor receptor on the proliferation of leukemic blast cells from patients with acute myeloblastic leukemia.
    Asano Y, Yokoyama T, Shibata S, Kobayashi S, Shimoda K, Nakashima H, Okamura S, Niho Y.
    Cancer Res; 1997 Aug 15; 57(16):3395-7. PubMed ID: 9270003
    [Abstract] [Full Text] [Related]

  • 17. Production of granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, and tumor necrosis factor alpha during remission and infections in patients with acute leukemia.
    Duru F, Ertem U, Taçyildiz N, Kirazli S.
    J Med; 1995 Aug 15; 26(5-6):241-52. PubMed ID: 8721901
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E, Bason C, Visani G, Gobbi M, Ottaviani E, Ghio R.
    Haematologica; 1994 Aug 15; 79(1):7-12. PubMed ID: 15378942
    [Abstract] [Full Text] [Related]

  • 19. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
    Meng FY, Xu B, Sun J, Yang Y, Niu JN.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep 15; 24(9):1051-2. PubMed ID: 15447861
    [Abstract] [Full Text] [Related]

  • 20. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
    Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N.
    Br J Cancer; 1999 Jan 15; 79(1):40-6. PubMed ID: 10408691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.